万维书刊网微信二维码

扫微信,关注编辑QQ!

您的位置:万维书刊网 >>sci/e期刊大全 >>医药卫生1>>内科

MEDICINA CLINICA《临床医学》 (官网投稿)

简介
  • 期刊简称MED CLIN-BARCELONA
  • 参考译名《临床医学》
  • 核心类别 SCIE(2023版), 外文期刊,
  • IF影响因子
  • 自引率7.60%
  • 主要研究方向医学-MEDICINE, GENERAL & INTERNAL 医学:内科

主要研究方向:

等待设置主要研究方向
医学-MEDICINE, GENERAL & INTERNAL 医学:内科

MEDICINA CLINICA《临床医学》(半月刊). Launched in 1943, Medicina Clínica is a fortnightly journal aimed at the promotion of clinical research&nb...[显示全部]
征稿信息

万维提示:

1、投稿方式:在线投稿。

2、期刊网址:

https://www.journals.elsevier.com/medicina-clinica/

3、投稿网址:

https://www.editorialmanager.com/medcli

4、期刊刊期:半月刊,一年出版24期。

2021527日星期四

                             

 

投稿须知【官网信息】

 

Guide for Authors

MEDICINA CLÍNICA, founded in 1946, is a journal devoted to promoting the research and the clinical practice among the specialist of internal medicine and other medical specialist. The journal publishes original scientific articles, editorials, short communications, reviews as well as other relevant information to internal medicine and related fields.

Types of article

Any article sent to this journal will follow the guidelines described in the section "Ethics in the publication" of this guide for authors, therefore it is essential to consult it before sending the manuscripts.

In particular, the manuscripts corresponding to the originals sections the authors must clearly indicate at the end of the section "Material and methods" that such guidelines have been followed, as well as the informed consent of the patients has been obtained and has been approved by the corresponding ethics committee. Likewise, in the manuscripts corresponding to the Scientific Letters section, the authors must clearly indicate in the articles body that the protocols and procedures of the institutional centres related with the patients data publication have been followed, as well as the subject privacy. In the section Images in medicine the authors should also indicate clearly in the article body that the protocols and procedures of the institutional centres related with the patient data publication have been followed, and the patients consents for its publication has been obtained, as well as the subject privacy has been respected.

Any article in this journal involving experiments with human or animal subjects will follow the guidelines in the Human and animal rights described in the Ethics in publishing section of this guide for authors. Authors should clearly indicate in the manuscript that such guidelines have been followed, as well as the statement that informed consent was obtained for experimentation with human subjects.

For any section of this journal: Original articles, Review articles, Short communications, Images and videos, the three epigraphs:Ethical considerations, Funding and Conflict of interest should be added at Essential title page information.

Ethical considerations: If the work involves the use of human subjects, the author should ensure that the work described has been carried out in accordance with The Code of Ethics of the World Medical Association(Declaration of Helsinki) for experiments involving humans; Uniform Requirements for manuscripts submitted to Biomedical journals. Authors should include a statement that informed consent was obtained for experimentation with human subjects, and all the ethical procedures were performed. The privacy rights of human subjects must always be observed. The approval of the institutional review board (IRB)or the appropriate committee must be stated in this epigraph.

Funding: You are requested to identify who provided financial support for the conduct of the research and/or preparation of the article and to briefly describe the role of the sponsor(s), if any, in study design; in the collection, analysis and interpretation of data; in the writing of the report; and in the decision to submit the article for publication. If the funding source(s) had no such involvement then this should be stated.

Conflict of interest: All authors must disclose any financial and personal relationships with other people or organizations that could influence (bias) their work, even if it is not directly related to the current manuscript. Examples of potential competing interests include employment, consultancies, stock ownership, honoraria, paid expert testimony, patent applications/registrations, and grants or other funding, as well as travel grants and participation in courses and conferences as a paid expert. If there are no interests to declare then please state this: 'Declarations of interest: none'.  

ORIGINAL ARTICLES

Original research about etiology, physiopathology, pathology, epidemiology, clinical aspects, diagnosis, prognosis and treatment are recommended for this section. Analytic studies like transversal surveys, case-controls studies, cohort studies and randomized controlled trials will be preferentially considered for publication.

The article must have the following headings: Introduction; Patients and Methods; Results; and Discussion. The text is limited to a maximum of 3,000 - 4,000 words, not including references, abstract and figure legends. The abstract is limited to a maximum of 250 words and need to be structured. There should be no more than 30 references. The total combined number of tables and figures should not exceed 6.

BRIEF REPORTS

Original research with a limited number of patients or sample, and specific objectives and results are suitable for this section. The article must have the same headings as those from Original Articles. The text is limited to a maximum of 1,300 words, not including references, abstract and figure legends. The abstract is limited to a maximum of 180 words and need to be structured. There should be no more than 10 references. The total combined number of tables and figures should not exceed 3. Up to 6 authors are accepted.

CLINICAL REPORTS/ CASE SERIES

Submitted studies from case series with a remarkable contribution to medical knowledge will be considered in this section. The text is limited to 1,700 words not including figure legends and references. There should be no more than 10 references. The total combined number of tables and figures should not exceed 4. The abstract is limited to a maximum of 180 words and need to be structured. Up to 4 authors are accepted.

REVIEW ARTICLES

Reviews of current work reflecting progress in various fields of medicine are requested from recognized specialists. Voluntary contributions will be subject to consideration by the Editorial Board. The text is limited to 4,200 words not including abstract, figure legends, and references. The abstract is limited to a maximum of 150 words and does not need to be structured. Up to 6 figures or tables will be accepted. References are limited to a maximum of 60. Up to 3 authors are accepted.

SPECIAL ARTICLES

Articles reflecting original opinions and interpretation of relevant topics, narrative and practical reviews are included in this section. Voluntary contributions will be subject to consideration by the Editorial Board. The text is limited to 4,000 words. Up to 4-5 figures or tables will be accepted. References are limited to a maximum of 30. Up to 4 authors are accepted.

DIAGNOSIS AND TREATMENT

Update articles focused on the progress of diagnosis and treatments, enhancing the benefits in continuous medical education for readers will be considered for this section. The text is limited to 3,600 words not including figure legends and references. There should be no more than 30 references. The total combined number of tables and figures should not exceed 4. Up to 3 authors are accepted.

CONSENSUS AND GUIDELINES STATEMENTS

Clinical practice guidelines and Consensus statements must be promoted and endorsed by at least two scientific societies or sponsored by Health authorities. An attached letter is required arguing the importance for the scientific community. Support tools such AGREE are required for the development of the clinical guidelines and consensus statements. The articles of this section will published completely at the WEB. In the print version only title, authors, affiliations and the structured abstract limited to a maximum of 250 words will be published.

Medicina Clinica does not accept to publish any Consensus Document or Clinical Guide that does not have the Funding and Conflict of Interest sections of all authorsperfectly detailed and completed.

EDITORIALS

They are always commissioned, although unsolicited editorials may occasionally be considered previous consultation with the Editor. The text is limited to a maximum of 2,000 words, tables and figures are not allowed. There should be no more than 20 references. Up to 2 authors are accepted.

IMAGES IN MEDICINE

Any kind of images (clinical, endoscopic, radiography, microbiological, pathological) of common medical conditions with visual remarks for learning are suitable for this section. The text is limited to a maximum of 200 words. Graphics resources (arrows, asterisk, etc..) can be mandatory for visual remarks. Articles of this section can be selected only for the Web edition.

SCIENTIFIC LETTERS

Letters containing original investigation with small number of cases and with an specific conclusion are the first choice for this section. Letters should contain fewer than 700 words, one table or figure and must contain no more than 5 references. Up to 3 authors are accepted.

LETTERS TO THE EDITOR

Letters related to articles published by the journal are the first choice for this section as well as letters providing opinions and unusual observations and experiences. The letters related with published articles must be received within three weeks after the publication of the article and will be sent to the author of the article, who will have 4 weeks in which to answer. Letters should contain fewer than 700 words, one table or figure, A and must contain no more than 5 references. After publication of the reply, no further correspondence will be accepted. Up to 3 authors are accepted.

The editorial office will inform authors of manuscript acceptance by the Editorial Board. In accordance with the referees reports, papers may be rejected or modifications suggested, if necessary. Authors are entirely responsible for the views, conclusions and methods presented in their manuscripts.

Contact details for submission

You can send your manuscript at https://www.editorialmanager.com/medcli.

Language

This journal is published in Spanish and in English language. Manuscripts can be sent in both languages. The journal will publish a version in printed and online format with the articles received in its original language, and another version only online with articles translated into English.

Ethics in publishing

Please see our information pages on Ethics in publishing and Ethical guidelines for journal publication.

Informed consent and patient details

Studies on patients or volunteers require ethics committee approval and informed consent, which should be documented in the paper. Appropriate consents, permissions and releases must be obtained where an author wishes to include case details or other personal information or images of patients and any other individuals in an Elsevier publication. Written consents must be retained by the author but copies should not be provided to the journal. Only if specifically requested by the journal in exceptional circumstances (for example if a legal issue arises) the author must provide copies of the consents or evidence that such consents have been obtained. For more information, please review the Elsevier Policy on the Use of Images or Personal Information of Patients or other Individuals. Unless you have written permission from the patient (or, where applicable, the next of kin), the personal details of any patient included in any part of the article and in any supplementary materials (including all illustrations and videos) must be removed before submission.

Declaration of interest

All authors must disclose any financial and personal relationships with other people or organizations that could inappropriately influence (bias) their work. Examples of potential competing interests include employment, consultancies, stock ownership, honoraria, paid expert testimony, patent applications/registrations, and grants or other funding. Authors must disclose any interests in two places: 1. A summary declaration of interest statement in the title page file (if double anonymized) or the manuscript file (if single anonymized). If there are no interests to declare then please state this: 'Declarations of interest: none'. 2. Detailed disclosures as part of a separate Declaration of Interest form, which forms part of the journal's official records. It is important for potential interests to be declared in both places and that the information matches. More information.

Submission declaration and verification

Submission of an article implies that the work described has not been published previously (except in the form of an abstract, a published lecture or academic thesis, see 'Multiple, redundant or concurrent publication' for more information), that it is not under consideration for publication elsewhere, that its publication is approved by all authors and tacitly or explicitly by the responsible authorities where the work was carried out, and that, if accepted, it will not be published elsewhere in the same form, in English or in any other language, including electronically without the written consent of the copyright-holder. To verify originality, your article may be checked by the originality detection service Crossref Similarity Check.

Preprints

Please note that preprints can be shared anywhere at any time, in line with Elsevier's sharing policy. Sharing your preprints e.g. on a preprint server will not count as prior publication (see 'Multiple, redundant or concurrent publication' for more information).

Use of inclusive language

Inclusive language acknowledges diversity, conveys respect to all people, is sensitive to differences, and promotes equal opportunities. Content should make no assumptions about the beliefs or commitments of any reader; contain nothing which might imply that one individual is superior to another on the grounds of age, gender, race, ethnicity, culture, sexual orientation, disability or health condition; and use inclusive language throughout. Authors should ensure that writing is free from bias, stereotypes, slang, reference to dominant culture and/or cultural assumptions. We advise to seek gender neutrality by using plural nouns ("clinicians, patients/clients") as default/wherever possible to avoid using "he, she," or "he/she." We recommend avoiding the use of descriptors that refer to personal attributes such as age, gender, race, ethnicity, culture, sexual orientation, disability or health condition unless they are relevant and valid. These guidelines are meant as a point of reference to help identify appropriate language but are by no means exhaustive or definitive.

Authorship

All authors should have made substantial contributions to all of the following: (1) the conception and design of the study, or acquisition of data, or analysis and interpretation of data, (2) drafting the article or revising it critically for important intellectual content, (3) final approval of the version to be submitted.

Changes to authorship

Authors are expected to consider carefully the list and order of authors before submitting their manuscript and provide the definitive list of authors at the time of the original submission. Any addition, deletion or rearrangement of author names in the authorship list should be made only before the manuscript has been accepted and only if approved by the journal Editor. To request such a change, the Editor must receive the following from the corresponding author: (a) the reason for the change in author list and (b) written confirmation (e-mail, letter) from all authors that they agree with the addition, removal or rearrangement. In the case of addition or removal of authors, this includes confirmation from the author being added or removed.

Only in exceptional circumstances will the Editor consider the addition, deletion or rearrangement of authors after the manuscript has been accepted. While the Editor considers the request, publication of the manuscript will be suspended. If the manuscript has already been published in an online issue, any requests approved by the Editor will result in a corrigendum.

Reporting clinical trials

Randomized controlled trials should be presented according to the CONSORT guidelines. At manuscript submission, authors must provide the CONSORT checklist accompanied by a flow diagram that illustrates the progress of patients through the trial, including recruitment, enrollment, randomization, withdrawal and completion, and a detailed description of the randomization procedure. The CONSORT checklist and template flow diagram are available online.

……

更多详情:

https://www.elsevier.com/journals/medicina-clinica/0025-7753/guide-for-authors


  • 万维QQ投稿交流群    招募志愿者

    版权所有 Copyright@2009-2015豫ICP证合字09037080号

     纯自助论文投稿平台    E-mail:eshukan@163.com


投稿问答最小化  关闭